SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: vestor who wrote (642)3/10/1998 8:22:00 PM
From: Thure Meyer   of 1837
 
You mean if the FDA approves their product. The answer is I don't know. I plan to call the company sometime this week and ask, maybe investor relations can give me a clue.

As to the bottom line, it could be quite significant. You should read post #630, go to dojo.ie and check out the Premarin article. E.g., if the market is worth 500million to 1billion and Duramed picks up only 10% the stock will fly. Also, I'm sure that marketing partners will be lining up at the door if they get approval, so that distribution, advertising, access to doctors, etc. won't be a problem.

Nevertheless, this is speculation. Drug lobbies are powerful.

Thure
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext